A Review on Rubella Vaccine: Iran (1975-2019)

Blac Abernathy, E.S., Hubschen, J.M., Muller, C.P., Jin, L., Brown, D., Komase, K., et al., 2011. Status of global virologic surveillance for rubella viruses. J Infect Dis 204 1, 524-532.

Amini, B., 1996. A study of relationship between antibody of Rubella antivirus and number of pregnancy. J Zanjan Univ Med Sci 170, 11-19.

Azami, M., Jaafari, Z., Soleymani, A., Badfar, G.H., Abbasalizadeh, S.H., 2019. Rubella Immunity in Pregnant Iranian Women: A Systematic Review and Meta-Analysis. Int J Fertil Steril 13, 169-177.

Banatvala, J., Peckham, C., 2007. Rubella Viruses (2007),

 

   Elsevier.

Beck, E.S., 1969. Review of studies with inactivated rubella virus. Am J Dis Child 118, 328-333.

Bordbar, N., Habibi, G., Shafiei, A., 2010. Sequence and Phylogenetic Analysis of Wild Type Rubella virus isolated in Iran. Iran J Virol.  4, 28-37.

Buynak, E.B., Hilleman, M.R., Weibel, R.E., Stokes, J., Jr., 1968. Live attenuated rubella virus vaccines prepared in duck embryo cell culture. I. Development and clinical testing. JAMA 204, 195-200.

Cutts, F.T., Robertson, S.E., Diaz-Ortega, J.L., Samuel, R., 1997. Control of rubella and congenital rubella syndrome (CRS) in developing countries, part 2: vaccination against rubella. Bull World Health Organ, 75, 69-80.

Cutts, F.T., Vynnycky, E., 1999. Modelling the incidence of congenital rubella syndrome in developing countries. Int J Epidemiol 28, 1176-1184.

Esteghamati, A., Gouya, M.M., Zahraei, S.M., Dadras, M.N., Rashidi, A., Mahoney, F., 2007. Progress in measles and rubella elimination in Iran. Pediatr Infect Dis J 26, 1137-1141.

Rahimi, F., Sarafnegad, A., Salarbehzadi, S., 1994. Survey of rubella immunity in Tehran. Azad University.

Farhoud, D., Siddiqui, H., Solati, A.S., Alinejad, Z., Mohammad Ibrahim, S., 1996. Prevalence of rubella in women of premarital or reproductive age. Iran J Health 24, 1-6.

Ghafourian Boroujerdinia, M., Mohammad Jaffari, R., Khodadady, A., 2003. Seroepidemiology of Rubella amog Pregnant Women in Ahwaz, Iran. Jundishapur Sci Med J 38.

Ghafourian Boroujerdinia, M., Pakzad, P., 1996. Evaluation of rubella in pregnant women and children with and congenital rubella in Khuzestan province. Med Sci J Ahwaz Uni Med Sci 19.

Hilleman, M.R., Buynak, E.B., Whitman, J.E., Jr., Weibel, R.W., Stokes, J., Jr., 1969. Live attenuated rubella virus vaccines. Experiences with duck embryo cell preparations. Am J Dis Child 118, 166-171.

Hobman, T., Chantler, J., 2007. Rubella virus. In: Knipe, D.M., Howley, P.M. (Eds.), Fields' Virology Text book, pp. 1069-1101.

Huygelen, C., Peetermans, J., Prinzie, A., 1969. An attenuated rubella virus vaccine (Cendehill 51 strain) grown in primary rabbit kidney cells. Prog Med Virol 11, 107-125.

Jafari, E., Mohammadi, A., Arabzadeh, S., Esna-Ashari, F.,

   Sadigh, Z., Shokri, G., et al., 2012. Evaluation of Cell Mediated Immunity following Rubella Vaccination Using Lymphocyte Proliferation. Iran J Virol  6, 20-26.

Kabiri, M., Moattari, A., 1993. The rubella immunosurveillance of Iranian females: an indication of the emergence of rubella outbreak in Shiraz, Iran. Iran J Med
Sci 18, 134-137.

Kirby, T., 2015. Rubella is eliminated from the Americas. Lancet Infect Dis 15, 768-769.

Kono, R., Hibi, M., Hayakawa, Y., Ishii, K., 1969. Experimental Vertical Transmission of Rubella Virus in Rabbits. The Lancet 293, 343-347.

Mahmoudi, M., Vahedi, E., 2007. Comparison of Immunity against Rubella before and after Measles–Rubella Vaccination in 15-23 year-old Women. Med J Mashhad Uni of Med Sci 50, 177-184.

Metcalf, C.J., Lessler, J., Klepac, P., Cutts, F., Grenfell, B.T., 2012. Impact of birth rate, seasonality and transmission rate on minimum levels of coverage needed for rubella vaccination. Epidemiol Infect 140, 2290-2301.

Meyer, H.M., Jr., Parkman, P.D., Panos, T.C., 1966. Attenuated rubella virus. II. Production of an experimental live-virus vaccine and clinical trial. N Engl J Med 275, 575-580.

Mirchamsy, H., 1996. Rubella virus. In: Mirchamsy, H. (Ed.), General Information about prevention and treatment with vaccine and serum, University of Tehran Press, pp. 241-213.

Mirchamsy, H., Shafyi, A., Bahrami, S., Kamali, M., Nazari, P., 1976. Use of human diploid cell MRC-5, for production of measles and rubella virus vaccines. Dev Biol Stand 37, 297-300.

Modarres, S., Oskoii, N.N., 1996. The immunity of children and adult females to rubella virus infection in Tehran. Iran J Med Sci 21, 69-73.

Naficy, K., Nategh, R., Ahangary, S., Mohsenin, H., 1970. Artificial challenge studies in rubella. Utilization of RA 27-3 rubella vaccines, rubella naturally acquired seropositives, and rubella susceptible children. Am J Dis Child 120, 520-523.

Naficy, K., Saidi, S., 1970. Serological survey on viral antibodies in Iran. Trop Geogr Med 22, 183-188.

Naficy, K., Saidi, S., Nategh, R., Mostatab, A., Akbarshahy, E., 1967. Comparative study of live attenuated and further attenuated measles vaccines in rural areas of Iran. Arch Gesamte Virusforsch 22, 11-22.

Nategh, R., Ebrahimpour, 1985. Evaluation of rubella immunity in women aged 18-15 years in East Azerbaijan.
Med J Uni Tabriz 1, 26-27.

Owada, Y., Yamane, Y., Nagashima, T., Adachi, A., Ikumi, H., 1973. Studies on the live attenuated rubella virus vaccine. II. Research concerning attenuation of "Takahashi

strain" isolated in Japan. Kitasato Arch Exp Med 46, 93-103.

Pakzad, P., Ghafourian, M., 1996. Rubella survey among pregnant women and congenitally infected infants in Khuzestan province. Med J Ahwaz 19, 56-66.

Pakzad, P., Moattari, A., 1987. Serological study of the immunity to Rubella infection among the adult girls, pregnant and non-pregnant women, resident in Ahwaz. Jundishapur Sci Med J 5, 52-60.

Parkman, P.D., Buescher, E.L., Artenstein, M.S., 1962. Recovery of rubella virus from army recruits. Proc Soc Exp Biol Med 111, 225-230.

Peetermans, J., Huygelen, C., 1967. Attenuation ob rubella virus by serial passage in primary rabbit kidney cell cultures. I. Growth characteristics in vitro and production of experimental vaccines at different passage levels. Arch Gesamte Virusforsch 21, 133-143.

Plotkin, S.A., Farquhar, J., Katz, M., Ingalls, T.H., 1967. A new attenuated rubella virus grown in human fibroblasts: evidence for reduced nasopharyngeal excretion. Am J Epidemiol 86, 468-477.

Plotkin, S.A., Farquhar, J.D., Katz, M., Buser, F., 1969. Attenuation of RA 27-3 rubella virus in WI-38 human diploid cells. Am J Dis Child 118, 178-185.

Plotkin, S.A., Orenstein, W.A., 2012. Rubella vaccine, Vaccines, Philadelphia WB Saunders.

Polk, B.F., Modlin, J.F., White, J.A., DeGirolami, P.C., 1982. A controlled comparison of joint reactions among women receiving one of two rubella vaccines. Am J Epidemiol 115, 19-25.

Rivailler, P., Abernathy, E., Icenogle, J., 2017. Genetic diversity of currently circulating rubella viruses: a need to define more precise viral groups. J Gen Virol 98, 396-404.

Sabin, A.P.S.A., 1969. Discussion on session V., the International Conference on Rubella Immunization. Amer J Dis Child pp. 378-380.

Sadigh, Z.A., Shafyi, A., Akhavizadegan, M.A., Sabiry, G.M., Sassani, A., 1998. Evaluation of immunogenicity in MMR vaccine prepared with (AIK-C, S#12, and TAKAHASHI) strains in adult volunteers. RAZI Institute.

 

Sadighi, J., Eftekhar, H., Mohammad, K., 2005. Congenital rubella syndrome in Iran. BMC Infect Dis 5, 44.

Saidi, S., 1972. Epidemiological survey of rubella immunity

   in Iran. Bull World Health Organ 46,563-565.

Sever, J.L., Schiff, G.M., Huebner, R.J., 1963. Inactivated rubella virus vaccine. J Lab Clin Med.

Shafyi, A., Mirchamsy, H., Yousefi, I., 1996. Immunology and vaccine failure in measles vaccination. Res Reconstruct Sci Educat Quarter Agricult Minist 31, 108-117.

Shafyi, A., Mohammadi, A., 2018. Measles Vaccines in Iran: A 50-Year Review of Vaccine Development, Production and Effectiveness (1967 - 2017). Jundishapur J Microbiol 11, e60725.

Shafyi, A., Shafiee, M., Mirchamsy, H., Mohammadi, A., Keshawarz, M., Taqavian, M., et al., 2005. Isolation of Rubella Virus from Patients with Progressive Rubella Pan-Encephalitis. Arch Razi Inst 59, 25-33.

Shishido, A., Ohtawara, M., 1976. Development of attenuated rubella virus vaccines in Japan. Jpn J Med Sci Biol 29, 227-253.

Veale, H., 1866. History of an Epidemic of Rötheln, with Observations on Its Pathology. Edinb Med J 12, 404-414.

WHO, 1991. Rubella and congenital rubella syndrome in developing countries. 14th meeting.

WHO, 2005. Rubella, Congenital rubella syndrome: Where are we? Division of Communicable Disease Control Newsletter.

WHO, 2009. Measles & Rubella Surveillance. Field Manual for Communicable Diseases Surveillance Staff WHO-MOH IRAQ.

WHO, 2018. Assessment report of the Global Vaccine Action Plan. World Health organization, Geneva.

Zahraei, S.M., Mokhtari-Azad, T., Sabouri, A., Khazaei, S., Karami, M., 2019. Sero-epidemiological evaluation of rubella immunity among pre-marriage women in Iran. Hum Vaccin Immunother 15, 2117-2120.